Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
about
Hereditary and familial colon cancerHereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingTumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.Influence of patient preferences on the cost-effectiveness of screening for lynch syndromeWhen is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromesRevised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsEconomic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention.A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families.Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Hereditary and common familial colorectal cancer: evidence for colorectal screening.The role of pathology in the management of patients with endometrial carcinoma.Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families.Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.Hysterectomy at the time of risk-reducing surgery in carriersThe cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancerEconomic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting
P2860
Q28280647-4D13DDA9-0863-4125-AD71-08D69FD6A28BQ34977063-4730DDBD-A145-488E-8B5A-A5223086A311Q34988799-4D198340-1A34-4497-BCCF-1C59DC20ABB5Q34994574-821F2C04-1684-431C-ACAA-51F0B83A2BA8Q35063442-25BE2202-DF24-4DBD-9DAA-298153EA332DQ35181103-641195F7-C768-49DB-BC12-845B822A39DEQ35596050-DBE67E74-A7DC-4985-8FEE-634131F2BB81Q35947752-E5C5C6A9-FEA9-4BD9-A591-24A1163960C9Q36157315-ECB06D09-1E8C-49CE-A698-345BB92BADA7Q36392688-B0CAFD2E-7068-4842-8430-3BCB11395E7FQ36416282-D64B08AD-D1A8-4EE1-8506-90C11E095CDEQ36824964-B2D6B65C-36BE-455C-BAE0-40D836D5E49CQ36848099-C039FB60-9585-4A82-8B27-3465C2D1D093Q37221783-FC7E9FA8-EE9D-4F2A-9D23-D5D71F707259Q37288004-934CE408-8B58-4350-8A45-B0B66A7E7EBCQ37838462-9B5125F3-441B-419D-AE4B-1D4D9DA4D7F0Q38185144-424A7267-AD62-46C3-8CF4-7265380D0C1FQ38241489-83EC8EFB-AB64-4E31-8542-3D7E2655BF19Q38287107-E00D1CBB-F864-42D8-8A08-63F2C0B7C8EDQ38686652-36CAAEAB-6866-46ED-90AA-B81C3DBE3508Q44435870-B70261EA-C12A-4DF6-B8A8-E95126A0DA3BQ46449074-4BE396F6-F6F9-4A96-B98E-C8FD23F1F79CQ51063696-A0D0397F-F732-4E8E-ADDE-E581C7B61A7CQ58581326-BD15EAB7-D007-488F-9087-1CD5BBDCC798Q58635831-35FCC3A2-4957-4627-AB71-852F37C69945Q58803015-62B7ECBF-E059-4B37-A3B4-E61E4F61DA19
P2860
Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@en
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@nl
type
label
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@en
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@nl
prefLabel
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@en
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@nl
P2093
P2860
P356
P1433
P1476
Cost-effectiveness analysis of ...... gic cancers in Lynch syndrome.
@en
P2093
Charlotte C Sun
Janice S Kwon
Karen H Lu
Kristin G White
Stephanie G Boyd-Rogers
Susan K Peterson
P2860
P304
P356
10.1002/CNCR.23554
P407
P577
2008-07-01T00:00:00Z